Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tschoep

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Cellular Biochemistry|August 14, 2001
Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanismW Zou, I Hakim, K Tschoep, et al.
Journal of Leukocyte Biology|July 9, 2002
Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODNB Jahrsdörfer, R Jox, L Mühlenhoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in miceG Hartmann, C Bidlingmaier, B Siegmund, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotidesK Tschoep, G Hartmann, R Jox, et al.
Oncogene|September 11, 2007
The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell deathA Banjac, T Perisic, H Sato, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Cellular Biochemistry|August 14, 2001
Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanismW Zou, I Hakim, K Tschoep, et al.
Journal of Leukocyte Biology|July 9, 2002
Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODNB Jahrsdörfer, R Jox, L Mühlenhoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in miceG Hartmann, C Bidlingmaier, B Siegmund, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotidesK Tschoep, G Hartmann, R Jox, et al.
Oncogene|September 11, 2007
The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell deathA Banjac, T Perisic, H Sato, et al.
Pageof 1